Advertisement

West Pharmaceutical Services, Inc. WST

Set alert

Price alert · WST

All alert types
407.88 USD -4.74 -1.15%

At close · Nov 2

407.88 0.00 0.00%

After hours · Nov 2, 4:34 PM ET

Bid
407.73 × 160
Ask
407.98 × 120
407.14 Day range 418.50
223.83 52-week range 438.27
YTD
+48.24%
1 year
+44.60%
Open
412.89
Prev close
412.62
Mkt cap
28.41B
Vol
1.46M
Avg vol
571.97K
EPS
7.81
P/E
52.23
Div yield
0.25%
More statistics
Low
407.14
High
418.50
Forward P/E
39.53
Beta
1.14
Short ratio
3.38
Inst. own
103.72%
Dividend
1.04
Ex-div date
Nov 9, 2026
Earnings
Feb 11, 2027
50-d avg
367.60
200-d avg
313.38
1y target
466.67

5Y chart

Chart tools
Interval

Events in this range
  • Nov 9, 2021Dividend: 0.18
  • Nov 10, 2021Dividend: 0.18
  • Jan 18, 2022Dividend: 0.18
  • Apr 19, 2022Dividend: 0.18
  • Jul 19, 2022Dividend: 0.18
  • Nov 8, 2022Dividend: 0.19
  • Nov 16, 2022Dividend: 0.19
  • Jan 24, 2023Dividend: 0.19
  • Apr 25, 2023Dividend: 0.19
  • Jul 25, 2023Dividend: 0.19
  • Nov 7, 2023Dividend: 0.2
  • Jan 30, 2024Dividend: 0.2
  • Apr 23, 2024Dividend: 0.2
  • Jul 31, 2024Dividend: 0.2
  • Nov 13, 2024Dividend: 0.21
  • Feb 7, 2025Dividend: 0.21
  • Apr 30, 2025Dividend: 0.21
  • Jul 30, 2025Dividend: 0.21
  • Oct 23, 2025Earnings: 1.96; estimate 1.68; surprise 16.67%
  • Nov 12, 2025Dividend: 0.22
  • Jan 28, 2026Dividend: 0.22
  • Feb 12, 2026Earnings: 2.04; estimate 1.83; surprise 11.48%
  • Apr 23, 2026Earnings: 2.13; estimate 1.68; surprise 26.79%
  • Apr 29, 2026Dividend: 0.22
  • Jul 23, 2026Earnings: 2.37; estimate 2.08; surprise 13.94%
  • Jul 29, 2026Dividend: 0.22
  • Oct 7, 2026Rating: Barclays · Overweight → Overweight
  • Oct 13, 2026Rating: TD Cowen · Buy → Buy
  • Oct 29, 2026Earnings: 2.66; estimate 2.2; surprise 20.91%
  • Oct 30, 2026Rating: Evercore ISI Group · Outperform → Outperform
  • Oct 30, 2026Rating: Barclays · Overweight → Overweight
  • Oct 30, 2026Rating: TD Cowen · Buy → Buy
  • Oct 30, 2026Rating: Citigroup · Buy → Buy
Signals (88)
NameDateAgo
RSI: OverboughtOct 26, 20261 week ago
MACD: Buy SignalOct 12, 20263 weeks ago
SMA: BullishSep 7, 20261 month ago
SMA: BearishAug 24, 20262 months ago
MACD: Sell SignalAug 24, 20262 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BearishJul 20, 20263 months ago
RSI: OverboughtJun 29, 20264 months ago
RSI: OverboughtMay 4, 20266 months ago
SMA: BullishApr 13, 20266 months ago
MACD: Buy SignalApr 13, 20266 months ago
SMA: BullishMar 23, 20267 months ago
SMA: BearishJan 19, 20269 months ago
SMA: BearishJan 12, 20269 months ago
MACD: Sell SignalJan 5, 202610 months ago
SMA: BullishDec 29, 202510 months ago
SMA: BearishDec 8, 202510 months ago
SMA: BullishNov 17, 202511 months ago
SMA: BearishNov 10, 202511 months ago
SMA: BullishAug 4, 20251 year ago
SMA: BearishJul 28, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BullishJul 21, 20251 year ago
SMA: BearishJul 14, 20251 year ago
SMA: BullishJun 2, 20251 year ago
MACD: Buy SignalMay 26, 20251 year ago
SMA: BearishMay 19, 20251 year ago
SMA: BullishMay 12, 20251 year ago
RSI: OversoldMar 17, 20251 year ago
SMA: BearishFeb 10, 20251 year ago
MACD: Sell SignalFeb 10, 20251 year ago
RSI: OversoldFeb 10, 20251 year ago
SMA: BearishFeb 3, 20251 year ago
SMA: BullishNov 18, 20241 year ago
SMA: BearishNov 11, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BullishOct 21, 20242 years ago
SMA: BearishSep 30, 20242 years ago
SMA: BullishSep 16, 20242 years ago
MACD: Buy SignalSep 16, 20242 years ago
SMA: BearishSep 2, 20242 years ago
SMA: BullishAug 26, 20242 years ago
RSI: OversoldJul 22, 20242 years ago
SMA: BearishMay 13, 20242 years ago
SMA: BullishApr 29, 20242 years ago
SMA: BearishApr 22, 20242 years ago
MACD: Sell SignalApr 22, 20242 years ago
SMA: BearishApr 8, 20242 years ago
SMA: BullishMar 11, 20242 years ago
SMA: BullishMar 11, 20242 years ago
SMA: BearishFeb 26, 20242 years ago
SMA: BearishFeb 26, 20242 years ago
SMA: BullishFeb 19, 20242 years ago
SMA: BearishFeb 12, 20242 years ago
SMA: BullishJan 29, 20242 years ago
MACD: Buy SignalJan 29, 20242 years ago
SMA: BullishJan 22, 20242 years ago
SMA: BearishJan 1, 20242 years ago
SMA: BullishDec 11, 20232 years ago
SMA: BearishOct 16, 20233 years ago
SMA: BearishSep 18, 20233 years ago
MACD: Sell SignalSep 11, 20233 years ago
MACD: Buy SignalAug 21, 20233 years ago
MACD: Sell SignalJul 24, 20233 years ago
MACD: Buy SignalJun 26, 20233 years ago
SMA: BullishJun 12, 20233 years ago
MACD: Sell SignalJun 5, 20233 years ago
SMA: BearishMay 15, 20233 years ago
RSI: OverboughtMay 1, 20233 years ago
RSI: OverboughtApr 10, 20233 years ago
SMA: BullishJan 23, 20233 years ago
SMA: BullishJan 9, 20233 years ago
SMA: BearishJan 2, 20233 years ago
SMA: BullishDec 19, 20223 years ago
SMA: BearishDec 12, 20223 years ago
SMA: BullishNov 28, 20223 years ago
MACD: Buy SignalNov 28, 20223 years ago
SMA: BearishNov 14, 20223 years ago
SMA: BullishNov 7, 20223 years ago
RSI: OversoldOct 31, 20224 years ago
MACD: Sell SignalSep 19, 20224 years ago
SMA: BearishAug 22, 20224 years ago
SMA: BullishJul 18, 20224 years ago
SMA: BearishJul 11, 20224 years ago
MACD: Buy SignalJul 11, 20224 years ago
SMA: BullishJun 27, 20224 years ago
SMA: BearishApr 11, 20224 years ago
SMA: BullishMar 14, 20224 years ago

Key statistics

Market cap
28.42B
Enterprise value
28.59B
Trailing P/E
45.79
Forward P/E
39.53
PEG ratio
3.21
Price / sales
8.37
Price / book
9.59
EPS (TTM)
8.91
Beta
1.14
Dividend yield
0.25%
Payout ratio
9.88%
Profit margin
18.81%
Revenue (TTM)
3.40B
Revenue growth
8.70%
Free cash flow
345.56M
Total cash
464.10M
Total debt
313.90M
Return on equity
21.23%
Shares outstanding
69.66M
Short % of float
3.38%
50-day average
367.60
200-day average
313.38

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 466.67 +14.4% upside
Target (low)
340.00
Target (mean)
466.67
Target (high)
500.00
Ratings (0m) 16 15 buy · 0 hold · 1 sell
  • Strong buy3
  • Buy12
  • Hold0
  • Sell0
  • Strong sell1

Next earnings

Feb 11, 2027

Expected Feb 11, 2027. Consensus EPS estimate 2.28.

Earnings history

Financials — quick view

All financials
WST Revenue — quarterly 874.50M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
WST Net income — quarterly 214.00M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
WST EPS — quarterly 3.04
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

WST recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 11, 2027Dec 30, 20262.27———
Oct 29, 2026Sep 30, 20262.202.66+0.46+20.91%
Jul 23, 2026Jun 30, 20262.082.37+0.29+13.94%
Apr 23, 2026Mar 31, 20261.682.13+0.45+26.79%
Feb 12, 2026Dec 31, 20251.832.04+0.21+11.48%
Oct 23, 2025Sep 30, 20251.681.96+0.28+16.67%

Upgrades / downgrades

WST analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026CitigroupmainBuyBuy
Oct 30, 2026TD CowenmainBuyBuy
Oct 30, 2026BarclaysmainOverweightOverweight
Oct 30, 2026Evercore ISI GroupmainOutperformOutperform
Oct 13, 2026TD CowenmainBuyBuy
Oct 7, 2026BarclaysmainOverweightOverweight

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on WST — it syncs with the Stock Master app.

Insider holders

WST insider holders
InsiderRelationLatest transactionDateShares held
BIRKETT BERNARD JOHNChief Financial OfficerConversion of Exercise of derivative securityFeb 17, 20257,520
BUTHMAN MARK ADirectorStock Award(Grant)May 3, 202644,308
FAVORITE ANNETTE FOfficerSaleSep 14, 202621,817
FEEHERY WILLIAM F.DirectorStock Award(Grant)May 3, 202632,519
GREEN ERIC MARKChief Executive OfficerConversion of Exercise of derivative securityFeb 17, 2026175,418
HOFMANN THOMAS WDirectorStock Award(Grant)May 5, 202544,637

Institution ownership

WST institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.55%6,651,7842.71BJun 29, 2026
Vanguard Capital Management LLC6.62%4,613,1341.88BJun 29, 2026
Vanguard Portfolio Management LLC5.76%4,015,7661.64BJun 29, 2026
FMR, LLC5.13%3,574,8161.46BJun 29, 2026
State Street Corporation4.81%3,348,6981.37BJun 29, 2026
Artisan Partners Limited Partnership3.46%2,411,792983.91MJun 29, 2026

Fund ownership

WST fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.22%2,242,860915.00MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard 500 Index Fund2.63%1,830,358746.71MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund2.20%1,530,738624.48MJun 29, 2026
Fidelity Contrafund1.61%1,120,323457.05MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Growth Index Fund1.35%940,525383.70MJun 29, 2026
iShares Trust-iShares Core S&P 500 ETF1.35%937,921382.63MSep 29, 2026
Advertisement